RU2011132235A - METHOD FOR FORECASTING THE COURSE OF ISCHEMIC HEART DISEASE - Google Patents
METHOD FOR FORECASTING THE COURSE OF ISCHEMIC HEART DISEASE Download PDFInfo
- Publication number
- RU2011132235A RU2011132235A RU2011132235/15A RU2011132235A RU2011132235A RU 2011132235 A RU2011132235 A RU 2011132235A RU 2011132235/15 A RU2011132235/15 A RU 2011132235/15A RU 2011132235 A RU2011132235 A RU 2011132235A RU 2011132235 A RU2011132235 A RU 2011132235A
- Authority
- RU
- Russia
- Prior art keywords
- hdl
- less
- blood serum
- course
- level
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Способ прогнозирования течения ишемической болезни сердца путем исследования сыворотки крови, отличающийся тем, что до и после лечения одновременно определяют в сыворотке крови ЛПВП, общий холестерин и ЛП (а) путем дополнительной обработки 0,3 мл 0,1%-ного раствора Тритона Х-100 и инкубации 15 мин при 20°C, перемешиванием смеси методом встряхивания 120 раз в 1 мин, дезинтеграцией, последующей инкубацией сыворотки крови больного с раствором Судана Б в течение 1 ч в темном термостате при 40°C, и затем внесения пробы в лунку в геле агарозы с площадью основания 4×20 мм для электрофореза и последующей фиксацией электрофореграмм, их высушиванием, денситометрией и при одновременном снижении уровня общего холестерина на 15% и более и ЛП (а) на 30% и более и увеличением ЛПВП более 30%, холестерина ЛПВП с 0,8 до 1,6 ммоль/л и более по сравнению с исходным уровнем прогноз течения заболевания считают благоприятным, способствующим переходу стенокардии напряжения из функционального класса III-IV в функциональный класс I-II, а при снижении общего холестерина менее 15%, уровня ЛП (а) менее 30% и увеличением ЛПВП менее 30%, холестерина ЛПВП менее 1,6 ммоль/л по сравнению с исходным прогноз считают неблагоприятным.A method for predicting the course of coronary heart disease by examining blood serum, characterized in that before and after treatment, both HDL, total cholesterol and LP (a) are simultaneously determined in blood serum by additional processing of 0.3 ml of a 0.1% solution of Triton X- 100 and incubation for 15 min at 20 ° C, stirring the mixture by shaking 120 times every 1 min, disintegrating, followed by incubating the patient’s blood serum with Sudan B solution for 1 h in a dark thermostat at 40 ° C, and then adding the sample to the well agarose gel with a base area 4 × 20 mm for electrophoresis and subsequent fixation of electrophoregrams, their drying, densitometry and at the same time lowering the level of total cholesterol by 15% or more and LP (a) by 30% or more and increasing HDL more than 30%, HDL cholesterol from 0, 8 to 1.6 mmol / L or more compared with the initial level, the prognosis of the course of the disease is considered favorable, contributing to the transition of angina from functional class III-IV to functional class I-II, and with a decrease in total cholesterol of less than 15%, the level of LP ( a) less than 30% and an increase in HDL less than 30% , HDL cholesterol less than 1.6 mmol / L compared with the initial prognosis is considered unfavorable.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2011132235/15A RU2481580C2 (en) | 2011-07-29 | 2011-07-29 | Method for prediction of clinical course of ischemic heart disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2011132235/15A RU2481580C2 (en) | 2011-07-29 | 2011-07-29 | Method for prediction of clinical course of ischemic heart disease |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2011132235A true RU2011132235A (en) | 2013-02-10 |
RU2481580C2 RU2481580C2 (en) | 2013-05-10 |
Family
ID=48789693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011132235/15A RU2481580C2 (en) | 2011-07-29 | 2011-07-29 | Method for prediction of clinical course of ischemic heart disease |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2481580C2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5547873A (en) * | 1994-02-22 | 1996-08-20 | Genzyme Corporation | Compositions for stabilizing proteins for long term dry storage and methods of making and using the compositions |
RU2398239C1 (en) * | 2009-02-02 | 2010-08-27 | Государственное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" | Method of predicting course of coronary heart disease |
-
2011
- 2011-07-29 RU RU2011132235/15A patent/RU2481580C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2481580C2 (en) | 2013-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gomez-Hurtado et al. | Novel CPVT-associated calmodulin mutation in CALM3 (CALM3-A103V) activates arrhythmogenic Ca waves and sparks | |
Coppini et al. | Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy | |
Sinner et al. | Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation | |
Flaker et al. | Cognitive function and anticoagulation control in patients with atrial fibrillation | |
Pedrotty et al. | Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes | |
Hofer et al. | Tracking of metabolic control from childhood to young adulthood in type 1 diabetes | |
Goldraich et al. | Transcoronary gradient of plasma microRNA 423-5p in heart failure: evidence of altered myocardial expression | |
Rainer et al. | Plasma miR-124-3p and miR-16 concentrations as prognostic markers in acute stroke | |
JP2015521475A5 (en) | ||
Skrzypczyk et al. | Renalase in children with chronic kidney disease | |
Voinescu et al. | A variable-number taandem repeat polymorphism in PER3 is not associated with chronotype in a population with self-reported sleep problems | |
Jean et al. | Senolytic effect of high intensity interval exercise on human skeletal muscle | |
Orces | The association between metabolic syndrome and the anti-aging humoral factor klotho in middle-aged and older adults | |
RU2011132235A (en) | METHOD FOR FORECASTING THE COURSE OF ISCHEMIC HEART DISEASE | |
Reed et al. | Low pH enhances connexin32 degradation in the pancreatic acinar cell | |
Wu et al. | Association of ADAMTS-7 levels with cardiac function in a rat model of acute myocardial infarction | |
RU2009103367A (en) | METHOD FOR ESTIMATING EFFECTIVENESS OF TREATMENT OF ISCHEMIC HEART DISEASE | |
RU2009103462A (en) | METHOD FOR FORECASTING THE COURSE OF ISCHEMIC HEART DISEASE | |
Rodríguez-Mañero et al. | Impact of new criteria for anticoagulant treatment in atrial fibrillation | |
RU2009145864A (en) | METHOD FOR Predicting Heart Dysadaptation in Children After Cardiac Surgery Correction of Congenital Heart Disease | |
RU2012147102A (en) | METHOD FOR PREDICTING THE COURSE OF ISCHEMIC HEART DISEASE | |
RU2011131413A (en) | METHOD FOR ESTIMATING EFFECTIVENESS OF TREATMENT OF ISCHEMIC HEART DISEASE | |
Muniz et al. | Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction | |
Wei et al. | Noise exposure and its relationship with postinfarction cardiac remodeling: implications for NLRP3 inflammasome activation | |
Li et al. | Correlation between HCN4 gene polymorphisms and lone atrial fibrillation risk |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20130730 |